FI924082A - Idiotypvaccination mot b-cellymfoma - Google Patents
Idiotypvaccination mot b-cellymfoma Download PDFInfo
- Publication number
- FI924082A FI924082A FI924082A FI924082A FI924082A FI 924082 A FI924082 A FI 924082A FI 924082 A FI924082 A FI 924082A FI 924082 A FI924082 A FI 924082A FI 924082 A FI924082 A FI 924082A
- Authority
- FI
- Finland
- Prior art keywords
- dendritic cells
- idiotype
- pulsed
- cells
- idiotypvaccination
- Prior art date
Links
- 210000004443 dendritic cell Anatomy 0.000 abstract 5
- 206010025323 Lymphomas Diseases 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
- C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
- C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49351190 | 1990-03-14 | ||
US07/493,511 US20030072751A1 (en) | 1990-03-14 | 1990-03-14 | Idiotypic vaccination against b cell lymphoma |
US9101683 | 1991-03-13 | ||
PCT/US1991/001683 WO1991013632A1 (en) | 1990-03-14 | 1991-03-13 | Idiotypic vaccination against b cell lymphoma |
Publications (3)
Publication Number | Publication Date |
---|---|
FI924082A true FI924082A (fi) | 1992-09-11 |
FI924082A0 FI924082A0 (fi) | 1992-09-11 |
FI105452B FI105452B (fi) | 2000-08-31 |
Family
ID=23960532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI924082A FI105452B (fi) | 1990-03-14 | 1992-09-11 | Idiotyyppirokotuksen valmistus B-solulymfoomaa vastaan |
Country Status (12)
Country | Link |
---|---|
US (1) | US20030072751A1 (fi) |
EP (1) | EP0521897B1 (fi) |
JP (1) | JP2735947B2 (fi) |
AT (1) | ATE124265T1 (fi) |
AU (1) | AU645552B2 (fi) |
CA (1) | CA2078235C (fi) |
DE (1) | DE69110877T2 (fi) |
DK (1) | DK0521897T3 (fi) |
ES (1) | ES2074268T3 (fi) |
FI (1) | FI105452B (fi) |
NO (1) | NO308509B1 (fi) |
WO (1) | WO1991013632A1 (fi) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6004807A (en) * | 1992-03-30 | 1999-12-21 | Schering Corporation | In vitro generation of human dendritic cells |
CA2133409C (en) * | 1992-04-01 | 2011-05-24 | Ralph M. Steinman | Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
AU687733B2 (en) * | 1992-04-01 | 1998-03-05 | Rockefeller University, The | Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
EP1421947A1 (en) * | 1992-07-22 | 2004-05-26 | The Trustees Of Princeton University | p53 vaccine |
DE69331703D1 (de) * | 1992-08-21 | 2002-04-18 | Us Gov Health & Human Serv | B-lymphomazellinie und antigen |
US5651993A (en) | 1992-11-18 | 1997-07-29 | Yale University | Specific immune system modulation |
CA2158281A1 (en) * | 1993-03-15 | 1994-09-29 | Jay A. Berzofsky | Peptide coated dendritic cells as immunogens |
WO1995034638A1 (en) * | 1994-06-14 | 1995-12-21 | The Board Of Trustees Of Leland Stanford Junior University | Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
US6300090B1 (en) | 1994-07-29 | 2001-10-09 | The Rockefeller University | Methods of use of viral vectors to deliver antigen to dendritic cells |
US6340981B1 (en) | 1997-06-30 | 2002-01-22 | Sun Microsystems, Inc. | Method and apparatus for stroke substitution |
US6010905A (en) * | 1995-01-27 | 2000-01-04 | The United States Of America As Represented By The Department Of Health & Human Services | Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells |
US5788963A (en) * | 1995-07-31 | 1998-08-04 | Pacific Northwest Cancer Foundation | Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
WO1997022349A1 (en) * | 1995-12-20 | 1997-06-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
US6080409A (en) | 1995-12-28 | 2000-06-27 | Dendreon Corporation | Immunostimulatory method |
US7659119B2 (en) | 1996-02-12 | 2010-02-09 | Argos Therapeutics, Inc. | Method and compositions for obtaining mature dendritic cells |
US5776746A (en) | 1996-05-01 | 1998-07-07 | Genitope Corporation | Gene amplification methods |
ATE428769T1 (de) | 1997-10-27 | 2009-05-15 | Univ Rockefeller | Methode und zusammensetzung zur herstellung von reifen dendritischen zellen |
CA2321093A1 (en) | 1998-02-20 | 1999-08-26 | The Rockefeller University | Apoptotic cell-mediated antigen presentation to dendritic cells |
US8313945B2 (en) | 1999-04-20 | 2012-11-20 | Yale University | Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
CA2368855C (en) | 1999-04-20 | 2012-05-29 | Richard Leslie Edelson | Differentiation of monocytes into functional dendritic cells |
US7030228B1 (en) | 1999-11-15 | 2006-04-18 | Miltenyi Biotec Gmbh | Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
AT409086B (de) * | 1999-11-16 | 2002-05-27 | Igeneon Krebs Immuntherapie | Neue verwendung von antikörpern als impfstoffe |
US8524495B2 (en) | 2007-05-16 | 2013-09-03 | Yale University | Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
-
1990
- 1990-03-14 US US07/493,511 patent/US20030072751A1/en not_active Abandoned
-
1991
- 1991-03-13 DE DE69110877T patent/DE69110877T2/de not_active Expired - Fee Related
- 1991-03-13 WO PCT/US1991/001683 patent/WO1991013632A1/en active IP Right Grant
- 1991-03-13 JP JP3506222A patent/JP2735947B2/ja not_active Expired - Lifetime
- 1991-03-13 CA CA002078235A patent/CA2078235C/en not_active Expired - Fee Related
- 1991-03-13 EP EP91905685A patent/EP0521897B1/en not_active Expired - Lifetime
- 1991-03-13 DK DK91905685.3T patent/DK0521897T3/da active
- 1991-03-13 ES ES91905685T patent/ES2074268T3/es not_active Expired - Lifetime
- 1991-03-13 AU AU74886/91A patent/AU645552B2/en not_active Ceased
- 1991-03-13 AT AT91905685T patent/ATE124265T1/de not_active IP Right Cessation
-
1992
- 1992-09-11 FI FI924082A patent/FI105452B/fi not_active IP Right Cessation
- 1992-09-11 NO NO923542A patent/NO308509B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH05507905A (ja) | 1993-11-11 |
CA2078235A1 (en) | 1991-09-15 |
EP0521897B1 (en) | 1995-06-28 |
AU7488691A (en) | 1991-10-10 |
ES2074268T3 (es) | 1995-09-01 |
DE69110877D1 (de) | 1995-08-03 |
EP0521897A1 (en) | 1993-01-13 |
CA2078235C (en) | 2004-01-20 |
JP2735947B2 (ja) | 1998-04-02 |
FI924082A0 (fi) | 1992-09-11 |
US20030072751A1 (en) | 2003-04-17 |
NO923542D0 (no) | 1992-09-11 |
AU645552B2 (en) | 1994-01-20 |
DE69110877T2 (de) | 1995-11-16 |
ATE124265T1 (de) | 1995-07-15 |
NO923542L (no) | 1992-09-11 |
NO308509B1 (no) | 2000-09-25 |
WO1991013632A1 (en) | 1991-09-19 |
FI105452B (fi) | 2000-08-31 |
DK0521897T3 (da) | 1995-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI924082A (fi) | Idiotypvaccination mot b-cellymfoma | |
IT1248760B (it) | Dispositivo di iniezione del combustibile per motori e endotermici | |
DK0504177T3 (da) | IL-11, et pattedyrcytokin | |
DK0669836T3 (da) | Terapeutisk anvendelse af kimære og radioaktivt mærkede antistoffer og humant B-lymfocytbegrænset differentieringsantigen til behandling af B-cellelymfom | |
DE3854174D1 (de) | Kraftstoffeinspritzventil. | |
ATE147633T1 (de) | Immunhilfsmittel aus liposome enthaltend lymphokin il -2 | |
ES2124533T3 (es) | Anticuerpos monoclonales inmunoestimulantes. | |
ATE71411T1 (de) | Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene. | |
MY135673A (en) | Monoclonal antibodies for inducing tolerance | |
BR8900510A (pt) | Injetor de combustivel | |
DE68912995D1 (de) | Kraftstoffeinspritzventil. | |
KR890700659A (ko) | 항원-특이적 t세포주의 생성방법 및 이의 치료적 용도 | |
IT1167325B (it) | Polverizzatore per iniettori del combustibile di motori diesel | |
IT8050422A0 (it) | Dispositivo per la riduzione delle vibrazioni di motori in particolare di motori endotermici ad iniezione | |
ATE111485T1 (de) | Peptidbehandlung von hartnäckigen infektionskrankheiten. | |
DK0542895T3 (da) | Krydsreaktiv influenza A immunisering | |
DE69322960D1 (de) | Empfängnisverhütender impfstoff | |
Thonard | Host defense mechanisms in the oral mucosa | |
NO872633L (no) | Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav. | |
IT1229943B (it) | Procedimento e dispositivo di misura dell'anticipo di inizio mandata dell'iniezione, particolarmente in motori diesel | |
IT1181513B (it) | Sistema di fissaggio dell'imbottitura sui fianchi di una poltrona | |
ITMI913291A1 (it) | Dispositivo e procedimento di iniezione del combustibile | |
SE8702038D0 (sv) | Sett och anordning for att alstra seismiska pulser | |
ES556316A0 (es) | Dispositivo verificador de inyectores de combustible | |
IT8304205V0 (it) | Iniettore di piccole dimensioni per motori diesel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |